BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27117766)

  • 1. [Randall-type monoclonal immunoglobulin deposition disease: From diagnosis to treatment].
    Cohen C; Javaugue V; Joly F; Arnulf B; Fermand JP; Jaccard A; Sirac C; Knebelmann B; Bridoux F; Touchard G
    Nephrol Ther; 2016 Jun; 12(3):131-9. PubMed ID: 27117766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.
    Cohen C; Royer B; Javaugue V; Szalat R; El Karoui K; Caulier A; Knebelmann B; Jaccard A; Chevret S; Touchard G; Fermand JP; Arnulf B; Bridoux F
    Kidney Int; 2015 Nov; 88(5):1135-43. PubMed ID: 26176826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
    Joly F; Cohen C; Javaugue V; Bender S; Belmouaz M; Arnulf B; Knebelmann B; Nouvier M; Audard V; Provot F; Gnemmi V; Nochy D; Goujon JM; Jaccard A; Touchard G; Fermand JP; Sirac C; Bridoux F
    Blood; 2019 Feb; 133(6):576-587. PubMed ID: 30578255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
    Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
    Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications.
    Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC
    Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
    Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
    Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
    Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
    Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
    BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, renal failure, and edema in a 38-year-old man: light chain deposition disease; a case report and review of the literature.
    Said S; J Cooper C; C Nwosu A; E Bilbao J; T Hernandez G
    J Nephropathol; 2014; 3(2):63-8. PubMed ID: 24772399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias.
    Gallo G; Picken M; Buxbaum J; Frangione B
    Semin Hematol; 1989 Jul; 26(3):234-45. PubMed ID: 2506646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.
    Ziogas DC; Kastritis E; Terpos E; Roussou M; Migkou M; Gavriatopoulou M; Spanomichou D; Eleutherakis-Papaiakovou E; Fotiou D; Panagiotidis I; Kafantari E; Psimenou E; Boletis I; Vlahakos DV; Gakiopoulou H; Matsouka C; Dimopoulos MA
    Leuk Lymphoma; 2017 Aug; 58(8):1832-1839. PubMed ID: 27967286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
    Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
    J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Fanconi syndrome secondary to light chain deposition disease associated with monoclonal gammopathy of renal significance: A case report.
    Tu H; Mou L; Zhu L; Jiang Q; Gao DS; Hu Y
    Medicine (Baltimore); 2018 Sep; 97(36):e12027. PubMed ID: 30200082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Gammopathy of Renal Significance with Deposits of Infrequent Morphology: Two Case Reports of Light and Heavy Chain Deposition Disease with Atypical Presentation and Literature Review.
    De La Flor JC; Monroy-Condori M; Apaza-Chavez J; Arenas-Moncaleano I; Díaz F; Guerra-Torres XE; Morales-Montoya JL; Lerma-Verdejo A; Sandoval E; Villa D; Vieru CM
    Medicines (Basel); 2023 Oct; 10(10):. PubMed ID: 37887262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.
    Stratta P; Gravellone L; Cena T; Rossi D; Gaidano G; Fenoglio R; Lazzarich E; Quaglia M; Airoldi A; Bozzola C; Monga G; Valente G; Canavese C; Magnani C
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):31-42. PubMed ID: 20570173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Immunoglobulin Deposition Disease and Related Diseases.
    Kanzaki G; Okabayashi Y; Nagahama K; Ohashi R; Tsuboi N; Yokoo T; Shimizu A
    J Nippon Med Sch; 2019; 86(1):2-9. PubMed ID: 30918151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.